Cancer Research UK logo.
SearchDonate
  • Search

A trial of talimogene laherparepvec and pembrolizumab for advanced melanoma (MASTERKEY-265)

Overview

Cancer types:

Melanoma

Status:

Closed

Phase:

Phase 3

Details

This trial is for people with melanoma skin cancer that cannot be removed by surgery or that has spread to other parts of the body (advanced melanoma).

Recruitment start: 2 May 2016

Recruitment end: 29 March 2018

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Kevin Harrington

Supported by

Amgen

Experimental Cancer Medicine Centre (ECMC)

Last reviewed: 2 April 2018

CRUK internal database number: 13832

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.